ctrl K

Third Harmonic Bio Inc. (THRD)

NASDAQ: THRD · Real-Time Price · USD

5.15

-0.02 (-0.39%)

At close: May 01, 2025, 3:59 PM

5.06

-1.75%

Pre-market: May 02, 2025, 06:56 AM EDT

Third Harmonic Bio Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	35K	38K	n/a	n/a
Gross Profit	n/a	-35K	-38K	n/a	n/a
Operating Income	58.87M	-43.95M	-37.71M	-19M	-11.12M
Interest Income	n/a	13.13M	2.55K	5.00	n/a
Pretax Income	45.47M	-30.82M	-35.16M	-29.61M	-12.81M
Net Income	45.47M	-30.82M	-37.71M	-29.61M	-12.81M
Selling & General & Admin	22.37M	19.99M	13.3M	3.26M	1.17M
Research & Development	36.5M	23.96M	24.41M	15.75M	9.95M
Other Expenses	n/a	n/a	2.55M	-10.61M	-1.69M
Operating Expenses	58.87M	43.92M	37.71M	19M	11.12M
Interest Expense	n/a	n/a	2.55M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-58.87M	43.95M	37.71M	19M	11.12M
Income Tax Expense	n/a	n/a	2.55M	-19K	-1K
Shares Outstanding (Basic)	41.73M	39.65M	39.38M	38.69M	38.69M
Shares Outstanding (Diluted)	41.73M	39.65M	39.38M	38.69M	38.69M
EPS (Basic)	1.09	-0.78	-0.96	-0.77	-0.33
EPS (Diluted)	1.09	-0.78	-0.96	-0.77	-0.33
EBITDA	-45.42M	-30.79M	-35.12M	-10.61M	-1.69M
EBIT	n/a	-30.82M	-35.16M	-29.61M	-12.81M
Depreciation & Amortization	n/a	35K	38K	19M	11.12M